ARTICLE | Clinical News
AR-12 regulatory update
May 11, 2015 7:00 AM UTC
The European Commission granted Orphan Drug designation to AR-12 from Arno to treat cryptococcosis and tularemia. The small molecule 3-phosphoinositide dependent protein kinase-1 (PDPK1) inhibitor is...